Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Convery, P. N.
Right arrow Articles by Gustafsson, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Convery, P. N.
Right arrow Articles by Gustafsson, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2001, Vol. 87, No. 4 570-576
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia

Clinical Investigations

Efficacy and uptake of ropivacaine and bupivacaine after single intra-articular injection in the knee joint

P. N. Convery1, K. R. Milligan1, P. Quinn1, J. Sjövall2 and U. Gustafsson2

1Musgrave Park Hospital, Belfast, UK. 2AstraZeneca R & D, Södertälje, Sweden.*Corresponding author: Department of Anaesthetics, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK**Present address, Belfast City Hospital, Belfast, UK

The efficacy of ropivacaine 100 mg (5 mg ml–1), 150 mg (7.5 mg ml–1) and 200 mg (10 mg ml–1) and bupivacaine 100 mg (5 mg ml–1) given by intra-articular injection into the knee after the end of surgery was studied in 72 ASA I–II patients scheduled for elective knee arthroscopy under general anaesthesia in a randomized, double-blind study. Kapake (paracetamol 1 g and codeine 60 mg) was given as a supplementary analgesic. Pain scores were assessed 1–4 h after surgery and a verbal rating scale of overall pain severity was assessed on second postoperative day. Ropivacaine or bupivacaine concentrations were determined in peripheral venous plasma up to 3 h after injection in eight patients in each group. Verbal rating pain scores were lower with ropivacaine 150 mg compared with bupivacaine 100 mg (P<0.05). There was a tendency for lower analgesic consumption and pain scores with all doses of ropivacaine (not significant). The mean (SD) maximum total plasma concentrations of ropivacaine were 0.64 (0.25), 0.78 (0.43), and 1.29 (0.46) mg litre–1 after 100, 150 and 200 mg. The corresponding unbound concentrations were 0.018 (0.009), 0.024 (0.020) and 0.047 (0.022) mg litre–1. Both were proportional to the dose. The maximum total concentration after bupivacaine 100 mg was 0.57 (0.36) mg litre–1. The time to reach maximum plasma concentration was similar for all doses and varied between 20 and 180 min. All concentrations were well below the threshold for systemic toxicity.

Br J Anaesth 2001; 87: 570–6


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
S. L. Piper and H. T. Kim
Comparison of Ropivacaine and Bupivacaine Toxicity in Human Articular Chondrocytes
J. Bone Joint Surg. Am., May 1, 2008; 90(5): 986 - 991.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.